Literature DB >> 10070050

Hepatocyte nuclear factor-4 regulates intestinal expression of the guanylin/heat-stable toxin receptor.

E S Swenson1, E A Mann, M L Jump, R A Giannella.   

Abstract

We have investigated the regulation of gene transcription in the intestine using the guanylyl cyclase C (GCC) gene as a model. GCC is expressed in crypts and villi in the small intestine and in crypts and surface epithelium of the colon. DNase I footprint, electrophoretic mobility shift assay (EMSA), transient transfection assays, and mutagenesis experiments demonstrated that GCC transcription is regulated by a critical hepatocyte nuclear factor-4 (HNF-4) binding site between bp -46 and -29 and that bp -38 to -36 were essential for binding. Binding of HNF-4 to the GCC promoter was confirmed by competition EMSA and by supershift EMSA. In Caco-2 and T84 cells, which express both GCC and HNF-4, the activity of GCC promoter and/or luciferase reporter plasmids containing 128 or 1973 bp of 5'-flanking sequence was dependent on the HNF-4 binding site in the proximal promoter. In COLO-DM cells, which express neither GCC nor HNF-4, cotransfection of GCC promoter/luciferase reporter plasmids with an HNF-4 expression vector resulted in 23-fold stimulation of the GCC promoter. Mutation of the HNF-4 binding site abolished this transactivation. Transfection of COLO-DM cells with the HNF-4 expression vector stimulated transcription of the endogenous GCC gene as well. These results indicate that HNF-4 is a key regulator of GCC expression in the intestine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070050     DOI: 10.1152/ajpgi.1999.276.3.G728

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells.

Authors:  Valérie Marcil; Ernest Seidman; Daniel Sinnett; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Louis-Philippe Precourt; Devendra Amre; Emile Levy
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease.

Authors:  Sung-Hoon Ahn; Yatrik M Shah; Junko Inoue; Keiichirou Morimura; Insook Kim; Sunhee Yim; Gilles Lambert; Reiko Kurotani; Kunio Nagashima; Frank J Gonzalez; Yusuke Inoue
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

Review 3.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

4.  Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis.

Authors:  Jian-Feng Zhang; Zhen-Biao Mao; Zeng-Li Li; Shi-Min Xue; Hui-Jun Zhu; Hong Zhang; Run-Zhou Ni
Journal:  Med Oncol       Date:  2011-10-05       Impact factor: 3.064

Review 5.  Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Authors:  Hari Prasad; John Kandam Kulathu Mathew; Sandhya S Visweswariah
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

6.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

Review 7.  Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C.

Authors:  Philipp R Weiglmeier; Paul Rösch; Hanna Berkner
Journal:  Toxins (Basel)       Date:  2010-08-26       Impact factor: 4.546

8.  The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.

Authors:  Øystein Brenna; Torunn Bruland; Marianne W Furnes; Atle van Beelen Granlund; Ignat Drozdov; Johanna Emgård; Gunnar Brønstad; Mark Kidd; Arne K Sandvik; Björn I Gustafsson
Journal:  Scand J Gastroenterol       Date:  2015-05-15       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.